Core Session 1: Precursor Disease

Chair(s)

• 

  Vincent Rajkumar, MD

  Edward W. and Betty Knight Scripps Professor of Medicine
  Mayo Clinic

Co-Chair(s)

• 

  Maria-Victoria Mateos, PhD (she/her/hers)

  Head of Unit
  University Hospital of Salamanca
  Salamanca, Castilla y Leon, Spain

Presentations:

• 09:30 - 09:40 East Coast USA Time

  Genomic profiling
  

  Speaker: Mehmet K. Samur, PhD – Dana Farber Cancer Institute, Harvard Medical School
• 09:40 - 09:50 East Coast USA Time

  Microenvironment
  

  Speaker: Madhav V. Dhodapkar, MD, (he/him/his) – Fred Hutch Cancer Center, Seattle, WA
• 09:50 - 10:00 East Coast USA Time

  What else is important in the transition from Smoldering to MM?
  

  Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland
• 10:00 - 10:10 East Coast USA Time

  Clinical management of precursor conditions
  

  Speaker: Natalie Callander, MD – University of Wisconsin
• 10:10 - 10:25 East Coast USA Time

  Future Directions and Challenges
  

  Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
• 10:25 - 10:50 East Coast USA Time

  Round Table discussion
  

  Panelist: Jesus San Miguel, PhD. MD. (he/him/his) – Cancer Center Clínica Universidad de Navarra

  Panelist: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

  Panelist: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

  Panelist: Peter Leif Bergsagel, MD – Mayo Clinic Arizona